DUBLIN, May. 02, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis" report to their offering.
Global Influenza Vaccine Market is worth more than US$ 5 Billion. Globally Pediatrics Influenza Vaccinated Population was more than 150 Thousand, but still this figure was significantly less than the Adult Influenza Vaccinated Population. As per our research Pediatrics Influenza Vaccinated population will decline in future and Adult Influenza Vaccinated Population will increase in forecast period.
United States has the highest market share in Influenza Vaccine Market. United States Influenza Vaccine Market Share was almost 4 times more than China and Japan Influenza Vaccine Market Share. United States & China together captures close to 60 percent in Pediatrics Influenza Vaccine Market Share. Whereas, in adult vaccination segments, United States and Japan will share more than 50 percent market share by 2022.
Global Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis is our 8th report on the Influenza Vaccine Market. This is a 383 page report with 386 Figures and 7 Tables provides data of 30 countries globally on Influenza Vaccine Market. The report provides data on Pediatrics and Adult Influenza Vaccinated Population Numbers and Market.
Scope of Study:
- Influenza Vaccine Market has been divided into two segments Pediatrics Influenza Vaccine Market and Adult Influenza Vaccine Market
- Influenza Vaccine Market share & Forecast, Pediatrics Influenza Vaccine Market share & Forecast and Adult Influenza Vaccine Market share & Forecast
- Influenza Vaccinated Population & Forecast has been divided into two segments Pediatrics Influenza Vaccinated Population & Forecast and Adult Influenza Vaccinated Population & Forecast
- Influenza Vaccine Brand Sales and Forecast
- Afluria/Fluvax and Fluvirin/Flucelvax
- Fluarix/ Flulaval
Key Topics Covered:
1 Executive Summary
2 Influenza - Introduction
3 Structure of Influenza Virus
4 Notable Influenza Pandemics
5 Worldwide Influenza Vaccinated Population
6 Worldwide Seasonal Influenza Vaccine Market
7 Worldwide Seasonal Influenza Vaccine Market Share Analysis
For more information about this report visit http://www.researchandmarkets.com/research/jkjbdw/global_influenza
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-influenza-vaccine-market---will-increase-to-us-574-billion-by-the-year-2022---research-and-markets-300449457.html
SOURCE Research and Markets